FDA releases two new Cell and Gene Therapy related draft Guidances for Industry (Cell and Gene Therapy Catapult – Regulatory Round-up – March 2022)
FDA releases two new Cell and Gene Therapy related draft Guidances for Industry, electronic or written comments on the draft guidance by June 14, 2022, see Considerations for the Development of Chimeric Antigen Receptor (CAR) T Cell Products .
See all of Catapult’s Regulatory Round-up for March 2022 here. Published on the 5th of April 2022.
OpenEdition vous propose de citer ce billet de la manière suivante :
adelage (3 août 2022). FDA releases two new Cell and Gene Therapy related draft Guidances for Industry (Cell and Gene Therapy Catapult – Regulatory Round-up – March 2022). ELSIBI. Consulté le 13 janvier 2026 à l’adresse https://doi.org/10.58079/o620





